Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
New Delhi: Pharmaceuticals and Medical Devices Bureau of India (PMBI) has introduced new variant of Diabetes medicines by PMBI at affordable prices under Pradhan Mantri Bhartiya Janaushadhi Pariyojana. Chief Executive Officer of PMBI Ravi Dadhich launched Sitagliptin a new variant of medicines for diabetes today at affordable prices for all under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana. PMBI included new variants of medicines Sitagliptin and its combination in its all Jan Aushdhi Kendras.
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. All these variants are available at 60 per cent to 70 per cent lesser prices than branded variants as they are available in price band of Rs 162 to Rs 258 at other medical stores.
Under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, more than 8700 Pradhan Mantri Bhartiya Janaushadhi Kendras have been opened across the country. These Kendras are selling quality generic medicines, surgical equipment, nutraceuticals and other products. At present, these Kendras make available more than 1600 medicines and 250 surgical devices including Suvidha Sanitary pads which are sold at Rs one per pad.
PMBI has said that it is committed to ensure regular and sufficient availability of essential medicines at the Jan Aushadhi Kendras and that too with assurance of good quality and affordable prices for citizens.
Pharmaceuticals & Medical Devices Bureau of India (PMBI) is the implementing agency of Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). PMBI was established in December, 2008 under the Department of Pharmaceuticals, Government of India.
